Medifast Inc (NYSE: MED) is a weight loss and metabolic health company that develops, manufactures, and sells portion-controlled meal replacement products and coaching-based wellness programs under the OPTAVIA brand. Revenue is generated through direct sales of food products to clients, routed through a network of independent contractor coaches who market and sell primarily via word-of-mouth and social media. Products are shipped directly to clients; coaches do not handle inventory. Medifast operates in the highly competitive metabolic health and weight loss industry, which includes commercial diet programs, prescription GLP-1 medications, over-the-counter supplements, digital health apps, and medically supervised programs. The company has operated for more than 40 years and uses a single-price model with no tiered pricing for coaches or clients. Approximately 90% of coaches were clients first, which the company describes as a core structural feature of its field organization. As of the fiscal year ended December 31, 2025, the company filed its 10-K on February 17, 2026.
OPTAVIA-branded meal replacement products, habit-based weight loss plans (including the OPTAVIA 5 & 1 Plan), coach-supported metabolic health programs, and community-based wellness support systems. The company launched new products in 2025 as noted in the FY2025 10-K.
Medifast earns revenue through direct product sales, primarily meal replacement and nutrition products shipped to end clients. Independent contractor coaches serve as the sales channel, earning compensation through a structured incentive plan rather than product markups or inventory management.
Direct-to-consumer end market targeting U.S. adults seeking weight loss and metabolic health improvement. Core clients are described as highly motivated health and wellness consumers. The addressable U.S. weight loss market is estimated at over $30 billion per a proprietary analysis cited in the FY2025 10-K.
Primarily United States, based on the filing's description of the client and coach base. No specific international revenue breakdown is supported by the provided excerpts.
Loading...